1 false false false false false false false false false true false false false false false false No description of principal activity 2022-07-04 Sage Accounts Production Advanced 2021 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 14214217 2022-07-04 2023-07-31 14214217 2023-07-31 14214217 bus:RegisteredOffice 2022-07-04 2023-07-31 14214217 bus:LeadAgentIfApplicable 2022-07-04 2023-07-31 14214217 bus:Director1 2022-07-04 2023-07-31 14214217 core:WithinOneYear 2023-07-31 14214217 bus:Micro-entities 2022-07-04 2023-07-31 14214217 bus:AuditExemptWithAccountantsReport 2022-07-04 2023-07-31 14214217 bus:FullAccounts 2022-07-04 2023-07-31 14214217 bus:SmallCompaniesRegimeForAccounts 2022-07-04 2023-07-31 14214217 bus:PrivateLimitedCompanyLtd 2022-07-04 2023-07-31
COMPANY REGISTRATION NUMBER: 14214217
JAM Life Sciences Limited
Filleted Unaudited Financial Statements
31 July 2023
JAM Life Sciences Limited
Financial Statements
Period from 4 July 2022 to 31 July 2023
Contents
Page
Officers and professional advisers
1
Statement of financial position and the notes to the financial statements
2
JAM Life Sciences Limited
Officers and Professional Advisers
Director
Mr J A Mullen
Registered office
Apartment 7.6b Melia House
2 Hornbeam Way
Manchester
M4 4AY
Accountants
Rose, Chartered Accountants
92a Bury Old Road
Whitefield
Manchester
M45 6TQ
Company number 14214217
JAM Life Sciences Limited
Statement of Financial Position
31 July 2023
Period from
4 Jul 22 to
31 Jul 23
£
£
Current assets
63,895
Creditors: amounts falling due within one year
51,994
--------
Net current assets
11,901
--------
Total assets less current liabilities
11,901
--------
Capital and reserves
11,901
--------
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the period amounted to 1 .
For the period ending 31 July 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The member has not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 2 April 2024 , and are signed on behalf of the board by:
Mr J A Mullen
Director
Company registration number: 14214217
The company is a private company limited by shares, registered in England and Wales.